BioCryst Pharmaceuticals (BCRX, $4.57) was one of the top gainers this week, climbing to $4.57 per share. A.I.dvisor analyzed 915 stocks in the Biotechnology Industry over the last week and discovered that of them (7) trended up while of them (2) trended down.